April 8th, 2021 – Présentation of annual results by Eric Dessertenne, CEO 210408_Annual results
BIOCORP signs two new partnerships with Mallya technology
Feb 17th, 2021 – Integration with digital applications developed by SocialDiabetes and Heath2Sync Opening of new high-potential international markets with…
Official commercial launch of Mallya
Nov 16, 2020 – Start of sales in Europe by the end of the year, followed by South Africa and Asia.Scale-up…
Partnership with AARDEX Group to Extend Smart Solutions for Precision Medication Adherence
Oct 1st, 2020 – By combining their key technologies, both companies offer innovative specific solutions for clinical trials and numerous…
Mallya will be distributed in France very soon
June 30th, 2020 – Thanks to the partnership signed with Roche Diabetes Care France, Mallya will soon be available for…
BIOCORP at Pharmapack 2020
We will attend Pharmapack once again! Please come and meet us on our booth #D58 on February 5th & 6th…
BIOCORP enters exclusive negotiations with SANOFI to use their Mallya connected device with Sanofi’s integrated diabetes care platform
Under the terms of these exclusive negotiations, BIOCORP will get an initial payment of €4 million from SANOFI to support…
BIOCORP wins the 2019 Award for Growth Companies
Yesterday, BIOCORP received the Grand Prix category “Healthcare, Pharma, Biotech & Medtech”. Created in partnership with the French Ministry of…
BIOCORP will attend the ADA in SF
The annual meeting of the ADA (American Diabetes Association) Will take place in San Francisco from June 7 to 10…
BIOCORP participates in RDD in Lisbon
BIOCORP exhibits its connected device, Inspair, during RDD in Lisbon Respiratory Drug Delivery summit is one of the largest and…
